Aug 19, 2026, 4:32 PM ETIndustrials

Nordson Corporation — Third Quarter Fiscal 2026 Earnings Summary

NDSNNORDSON CORP

Financial Performance

Third quarter sales reached a record $818 million, a 10% increase year-over-year from $742 million.
Organic sales growth was approximately 12%, partially offset by unfavorable impacts from a prior year divestiture and a second-quarter acquisition.
Net income was $153 million, or $2.73 per diluted share, compared to $126 million or $2.22 per diluted share in the prior year.
Adjusted earnings per diluted share were a record $3.25, a 19% increase from $2.73 in the prior year.
Third quarter EBITDA reached a record $262 million (32% of sales), up 10% from $239 million in the prior year.
Nine-month sales totaled $2.23 billion, a 9% increase from $2.04 billion.
Nine-month net income was $404 million, or $7.20 per diluted share, compared to $333 million or $5.83 per diluted share.
Nine-month adjusted earnings per diluted share were $8.48, up from $7.20.
Nine-month EBITDA was $701 million (31% of sales), up from $644 million (32% of sales).
Gross margin was 55.5% for the quarter, up from 54.8% in the prior year.
Free cash flow for the nine months ended July 31, 2026, was $530 million, with a conversion rate of 125% relative to adjusted net income.
Free cash flow for the quarter was $237 million.
Cash and cash equivalents were $113 million as of July 31, 2026.
Total debt (short-term and long-term) was $1.73 billion as of July 31, 2026.

Full-year sales guidance increased to a range of $3,035 million to $3,075 million.
Full-year adjusted earnings per diluted share guidance increased to a range of $11.80 to $12.00.
Backlog is up 35% compared to the prior year.
Management expects strong sales momentum from the first nine months to continue through the fourth quarter.
The company targets achieving over $3 billion in annual revenue for the full year.

Industrial Precision Solutions: Sales were $367 million (up 5% YoY), driven by an organic increase of 3%. EBITDA was $130 million (35% of sales). Growth was driven by packaging, industrial coatings, polymer processing, and nonwovens.
Medical and Fluid Solutions: Sales were $231 million (up 5% YoY), with an organic increase of 11% excluding a divestiture. EBITDA was a record $88 million (38% of sales). Growth was driven by engineered fluid solutions and medical product lines.
Advanced Technology Solutions: Sales were $220 million (up 28% YoY), driven by an organic increase of 31%. EBITDA was a record $66 million (30% of sales), up 58% from the prior year. Growth was driven by electronics dispense and test and inspection product lines.

Demand strength was observed across all segments.
Asia Pacific sales grew 22.2% year-over-year in the quarter, driven by a 24.1% organic increase.
Americas sales grew 5.4% year-over-year in the quarter.
Europe sales grew 3.1% year-over-year in the quarter.
The company leverages a diversified portfolio and differentiated precision technology to maintain best-in-class margin performance.

Forward-looking statements involve risks including U.S. and international economic and political conditions, financial and market conditions, and currency exchange rates.
Risks include the ability to successfully integrate acquisitions or divest businesses not fitting the strategic plan.
Potential impacts from changes in U.S. trade policy, tariffs, and tax law.
Risks related to political unrest, conflicts in Europe and the Middle East, acts of terror, natural disasters, and pandemics.

CEO Sundaram Nagarajan stated the company delivered results above the high-end of recent earnings guidance.
Management credited the "Ascend Strategy," diversified portfolio, precision technology, and operational excellence for record sales and margin performance.
Management highlighted strong free cash flow generation enabling balance sheet strengthening, capital returns to shareholders, and continued business investment.
The tone was confident, citing "strong momentum" and "best-in-class margin performance."

The company returned capital to shareholders through dividends and share repurchases.
Nine-month dividends paid were $137 million.
Nine-month purchase of treasury shares was $159 million.
Nine-month repayment of debt net was $258 million.
An acquisition was completed in the second quarter, contributing to sales growth.
A divestiture of a contract manufacturing business occurred in the prior year, impacting organic sales comparisons.
A non-cash loss on a minority investment was recognized during the quarter.
A pension settlement charge of $24 million was recognized in the nine-month period of the prior year.